US FDA slams Korean OTC maker: All employees ‘lack knowledge of GMP requirements’
The US regulator has issued Barox a warning letter citing labelling, storage and quarantine violations in Seongnam, South Korea.
The US regulator has issued Barox a warning letter citing labelling, storage and quarantine violations in Seongnam, South Korea.
The Supreme Court ruled that Fresenius was within its rights to terminate the merger agreement with Akorn.
Sandoz will launch its epinephrine generic in early 2019 at a lower price point than rival generics on the market.
Trianni to provide MacroGenics with humanized mouse model platform for its mAb therapeutics research.
Clinerion and Santa Casa da Misericordia hospital are partnering to bring clinical trial opportunities to patients and diverse data to CROs and sponsors.
Delivery by inhalation could be an easier way to deliver therapies in areas such as oncology, suggested ACG’s development manager.
Parexel and Eli Lilly are launching a clinical research learning and development program in China as recent reforms have “dramatically” increased the need for new sites in the country.